Skip to content

For example, a topical corticosteroid could treat psoriasis locally or could cause local skin thinning

Refrain from abruptly discontinuing a topical steroid as it can cause your psoriasis to flare. Low-strength steroids are good for treating the face, groin and breasts, but care must be taken as the risk of side effects is greater in sensitive skin areas. Potential side effects of topical steroids include skin damage, such as skin thinning, changes in pigmentation, easy bruising, stretch marks, redness and dilated surface blood vessels. Outsmart psoriasis and psoriatic arthritis from the inside out at this local event. Topical steroids are medicines that are used to treat a large number of conditions that cause inflammation – for example, eczema, psoriasis, hay fever. Topical steroids can be applied to the skin, eyes and nose as well as being inhaled into the lungs or inserted into the rectum. When they are used in the right way they have very few side-effects, and they have far fewer side-effects than steroid tablets (oral steroids). For example, people who have eczema or psoriasis usually apply their steroid creams or ointments once or twice a day. Thinning of the skin. Directory Patient Local Patient Access. Learn about steroids and the skin and when they are used to treat inflammatory skin disorders. For psoriasis, treatment success has been highly variable across studies, which have also suffered from poor methodology. Examples can be obtained from the British Association of Dermatologists and the National Eczema Society.

For example, a topical corticosteroid could treat psoriasis locally or could cause local skin thinning 2Learn about the different types of hair loss that can occur and the various treatment options and drugs that are available. Male pattern baldness involves a receding hairline and thinning around the crown with eventual bald spots. Traction alopecia – certain hairstyles such as when you pull on your hair tightly can cause scarring of the hair follicles. For alopecia areata, corticosteroids can be administered either as local injections, given orally or applied topically. Describe indications for use of topical corticosteroids of different classes of potency for dermatologic conditions. Psoriasis, vitiligo, lichen sclerosus, atopic dermatitis, eczema, and acute radiation dermatitis can be treated with topical steroids. It is used as a treatment for local psoriasis, as betamethasone dipropionate and salicylic acid, or as the combination betamethasone/calcipotriol.

Here, the virus causes local inflammation in the skin, with the formation of blisters. Skin cancer is a malignant growth on the skin, which can have many causes, including repeated severe sunburn or long-term exposure to the sun. Ointment and creams containing coal tar, dithranol (anthralin), corticosteroids, vitamin D3 analogues (for example, calcipotriol), and retinoids are routinely used. Psoriasis which is resistant to topical treatment and phototherapy is treated by medications that are taken internally by pill or injection. Corticosteroids – topical (skin), nose, and eyes. Last revised in September 2015 Corticosteroids – topical (skin), nose, and eyes. D000287Administration, Topical. D000305Adrenal Cortex Hormones. Drugs and devices. Inappropriate use of corticosteroid preparations in terms of any one of the following variables can cause both local and systemic adverse effects: quantity per application, frequency of application, duration of treatment, potency, vehicle used and site of application. For example, mometasone has pharmacologically active breakdown products, whereas fluticasone does not, which makes the former theoretically less safe on prolonged use. Both of the above increase skin maceration increasing the possibility of significant systemic absorption of locally applied corticosteroids, as well as promoting microbial overgrowth.

Hair Loss: Medications & Treatment Options

Logically, antirejection drugs, biologics, or other agents delivered locally to the VCA may reduce the need for systemic immunosuppression with its adverse effects. Several strategies exist for local delivery of immunosuppressive/immunomodulatory therapies in VCAs: (1) topical therapies are applied to the surface of the skin but do not effectively overcome the skin barrier, for example, therapies for psoriasis or atopic dermatitis; Sirolimus has been mainly used systemically in SOT, but topical treatment has also been reported in an experimental/preclinical setting in dermatology. Compared to topical steroids, which can result in collagen atrophy and skin thinning, tacrolimus has few local adverse effects 49. It is incurable and presents equally in both men and women and can occur at any age. Trauma to the skin – for example, from a surgical excision, tattooing or even areas of sunburn or scratch marks – can lead to psoriatic lesions, known as the isomorphic response or Knobner’s phenomenon. Topical steroids, used in conjunction with emollients – while not generally accepted as a mainstay treatment for psoriasis – are useful where the condition affects the face or flexures. Muperacin (Bactroban cream) is an excellent preparation and can control soft tissue infection alone in mild cases or combined with systemic antibiotics. Cefadroxil, cephalexin and cephradine are effective in the treatment of skin and soft tissue infections caused by Streptococcus species and methicillin-sensitive S. Oil of Cade or crude coal tar can be added to treat cases of psoriasis and seborrheic dermatitis. Topical corticosteroids in combination with salicylic acid (Locasalen, Salidecoderm, Diprosalic ointment) may also give good results either applied directly to the hyperkeratotic areas or under occlusion methods. Potential cutaneous complications associated with the use of topical corticosteroids include thinning of the skin, development of striae (stretch marks), development of purpura, pigmentary changes (hypo- or hyperpigmentation), acneiform eruptions, and increased risk of infections. However, this patient’s skin lesions are not consistent with EM, and EM does not cause lymphadenopathy, aminotransferase elevations, or eosinophilia. Patients with a history of psoriasis who are treated with systemic corticosteroids may develop an acute pustular erythrodermic flare days to weeks after the systemic corticosteroids are discontinued. The patient should be sent to an experienced dermatologist for a broad, paper-thin shave biopsy to sample the lesion.

America’s Top Dermatologists